This Article Full Text Full Text (PDF) All Versions of this Article: 91/5/1826    most recent Author Manuscript (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hwa, V. Articles by Rosenfeld, R. G. Search for Related Content PubMed PubMed Citation Articles by Hwa, V. Articles by Rosenfeld, R. G. Related Collections Neuroendocrinology and Pituitary Pediatric Endocrinology Metabolism

Total Absence of Functional Acid Labile Subunit, Resulting in Severe Insulin-Like Growth Factor Deficiency and Moderate Growth Failure

Department of Pediatrics (V.H., K.L.P., B.M.L., R.G.R.), Oregon Health and Science University, Portland, Oregon 97239-3098; Department of Pediatrics (G.H., H.F., D.K.), Medical University of Vienna, Vienna, Austria, A-1090; Lucile Packard Foundation for Children’s Health (R.G.R.), Palo Alto, California 94304; and Department of Pediatrics (R.G.R.), Stanford University, Stanford, California 94305-2038

Address all correspondence and requests for reprints to: Dr. Vivian Hwa, Department of Pediatrics, NRC5, Oregon Health and Science University, 3181 Southwest Sam Jackson Park Road, Portland, Oregon 97239-3098. E-mail: hwav{at}ohsu.edu.

Context: Primary IGF deficiency (IGFD) describes the condition in which serum concentrations of IGF-I are low in the face of normal to elevated GH production. Because IGF-I, which circulates as part of a ternary complex with IGF binding protein (IGFBP)-3 and acid-labile subunit (ALS), mediates the growth-promoting effects of GH, IGFD is associated with severe growth failure in humans.

Objective: We investigated a case of IGFD in which serum IGF-I and IGFBP-3 were abnormally low, yet growth failure was modest (–2.1 SD score at 15.5 yr of age).

Results: The young male subject, from a consanguineous pedigree, had a postnatal growth profile consistently below the third percentile. The subject had a normal fasting GH level of 3.7 µU/ml and normal serum GH binding protein level (1258 pmol/liter; normal range 431-1892 pmol/liter), but serum IGF-I and IGFBP-3 were profoundly reduced (–5.8 and –7.2 SD score, respectively, at age 12.3 yr), even through puberty. A novel homozygous missense mutation was subsequently identified in the ALS gene, which resulted in severe deficiency of serum ALS (undetectable).

Conclusions: ALS is critical for maintaining normal serum concentrations of IGF-I and IGFBP-3, most likely by prolonging the half-lives of both proteins. ALS deficiency can be associated with moderate growth failure, but in this patient, the onset and progression of puberty appear to be normal. Altogether the results support a modest role for the ternary complex in the regulation of stature.

This article has been cited by other articles:

				R. Murphy, J. Baptista, J. Holly, A. M. Umpleby, S. Ellard, L. W. Harries, J. Crolla, T. Cundy, and A. T. Hattersley Severe Intrauterine Growth Retardation and Atypical Diabetes Associated with a Translocation Breakpoint Disrupting Regulation of the Insulin-Like Growth Factor 2 Gene J. Clin. Endocrinol. Metab., November 1, 2008; 93(11): 4373 - 4380. [Abstract] [Full Text] [PDF]

				H A van Duyvenvoorde, M J E Kempers, T. B Twickler, J van Doorn, W J Gerver, C Noordam, M Losekoot, M Karperien, J M Wit, and A R M M Hermus Homozygous and heterozygous expression of a novel mutation of the acid-labile subunit Eur. J. Endocrinol., August 1, 2008; 159(2): 113 - 120. [Abstract] [Full Text] [PDF]

				K. E. Heath, J. Argente, V. Barrios, J. Pozo, F. Diaz-Gonzalez, G. A. Martos-Moreno, M. Caimari, R. Gracia, and A. Campos-Barros Primary Acid-Labile Subunit Deficiency due to Recessive IGFALS Mutations Results in Postnatal Growth Deficit Associated with Low Circulating Insulin Growth Factor (IGF)-I, IGF Binding Protein-3 Levels, and Hyperinsulinemia J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1616 - 1624. [Abstract] [Full Text] [PDF]

				I Banerjee, D Hanson, R Perveen, A Whatmore, G C Black, and P E Clayton Constitutional delay of growth and puberty is not commonly associated with mutations in the acid labile subunit gene. Eur. J. Endocrinol., April 1, 2008; 158(4): 473 - 477. [Abstract] [Full Text] [PDF]

				H. M. Domene, P. A. Scaglia, A. Lteif, F. H. Mahmud, S. Kirmani, J. Frystyk, P. Bedecarras, M. Gutierrez, and H. G. Jasper Phenotypic Effects of Null and Haploinsufficiency of Acid-Labile Subunit in a Family with Two Novel IGFALS Gene Mutations J. Clin. Endocrinol. Metab., November 1, 2007; 92(11): 4444 - 4450. [Abstract] [Full Text] [PDF]

				M J E Walenkamp and J M Wit Genetic disorders in the GH IGF-I axis in mouse and man Eur. J. Endocrinol., August 1, 2007; 157(suppl_1): S15 - S26. [Abstract] [Full Text] [PDF]

				R. G Rosenfeld IGF-I therapy in growth disorders Eur. J. Endocrinol., August 1, 2007; 157(suppl_1): S57 - S60. [Abstract] [Full Text] [PDF]

				N. Bouhours-Nouet, F. Gatelais, F. Boux de Casson, S. Rouleau, and R. Coutant The Insulin-Like Growth Factor-I Response to Growth Hormone Is Increased in Prepubertal Children with Obesity and Tall Stature J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 629 - 635. [Abstract] [Full Text] [PDF]